TY - JOUR
T1 - Reducing research waste in benign gynaecology and fertility research
AU - Duffy, JMN
AU - Bhattacharya, S
AU - Herman, M
AU - Mol, B
AU - Vail, A
AU - Wilkinson, J
AU - Farquhar, C
AU - Cochrane Gynaecology and Fertility Group
N1 - Funding
The commentary was not funded.
Acknowledgements
The authors would like to thank the 1000 authors, from over 45 countries, who have contributed to 200 reviews, and who are committed to reducing research waste; and the delegates who attended the Cochrane Gynaecology and Fertility 2016: Advancing Women's Health Through Evidence meeting held at the University of Oxford, UK (1–3 April 2016).
PY - 2017/2
Y1 - 2017/2
N2 - The past three decades have seen considerable change in the understanding of clinical research methods. There has been an acceptance that randomised controlled trials are the best way of establishing treatment effectiveness and a recognition that, while single studies are useful, pooling knowledge from all available randomised trials is likely to provide the best evidence to guide clinical practice. Advances in methodology have accompanied technological innovations in gynaecology and reproductive medicine, such as assisted reproduction, assessment of male fertility, ovulation induction, and laparoscopic surgery. In particular, high-quality systematic reviews have become important tools enabling evidence-based healthcare decisions and identifying gaps in evidence. The Cochrane Gynaecology and Fertility Group has recently celebrated 20 years of preparing and publishing systematic reviews with a symposium at the University of Oxford. With nearly a thousand authors and over 200 reviews, we are well aware of the need for making research more efficient, accessible and influential. This could be achieved by reducing research waste and addressing outcome reporting bias by developing and implementing core outcome sets.[1]
AB - The past three decades have seen considerable change in the understanding of clinical research methods. There has been an acceptance that randomised controlled trials are the best way of establishing treatment effectiveness and a recognition that, while single studies are useful, pooling knowledge from all available randomised trials is likely to provide the best evidence to guide clinical practice. Advances in methodology have accompanied technological innovations in gynaecology and reproductive medicine, such as assisted reproduction, assessment of male fertility, ovulation induction, and laparoscopic surgery. In particular, high-quality systematic reviews have become important tools enabling evidence-based healthcare decisions and identifying gaps in evidence. The Cochrane Gynaecology and Fertility Group has recently celebrated 20 years of preparing and publishing systematic reviews with a symposium at the University of Oxford. With nearly a thousand authors and over 200 reviews, we are well aware of the need for making research more efficient, accessible and influential. This could be achieved by reducing research waste and addressing outcome reporting bias by developing and implementing core outcome sets.[1]
U2 - 10.1111/1471-0528.14438
DO - 10.1111/1471-0528.14438
M3 - Comment/debate
C2 - 28120536
VL - 124
SP - 366
EP - 369
JO - BJOG-An International Journal of Obstetrics and Gynaecology
JF - BJOG-An International Journal of Obstetrics and Gynaecology
SN - 1470-0328
IS - 3
ER -